Impact of Surgical Resection of Metastases Refractory to Systemic Therapy on Survival and Quality of Life – a Phase II Trial

Publisher： Karger

E-ISSN： 2296-5262|22|6|486-489

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.6, 2000-01, pp. : 486-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Systemic Recombinant Interleukin-2 in the Treatment of Refractory Nasopharyngeal Carcinoma

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 110-115

Karger

Access to resources Recommend Favorite

The impact of portal pedicle clamping on survival from colorectal liver metastases in the contemporary era of liver resection: a matched cohort study

By  

HPB, Vol. 17, Iss. 9, 2015-09 ,pp. : 796-803

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second-Line Therapy in Refractory Pancreatic Cancer. Results of a Phase II Study

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 99-102

Karger

Access to resources Recommend Favorite

Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open‐label, single‐arm, noncomparative trial

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 61-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial)

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 3, 2018-02 ,pp. : 244-251

John Wiley & Sons Inc

Access to resources Recommend Favorite